Horse Anti-Rabies Virus IgG (Fab2), neutralizing |
RBV16-Fab2 |
Alpha Diagnostics |
100 ul |
EUR 534 |
Human IgG antibody Laboratories manufactures the wild-type virus neutralizing antibody reagents distributed by Genprice. The Wild-Type Virus Neutralizing Antibody reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact virus Antibody. Other Wild-Type products are available in stock. Specificity: Wild-Type Category: Virus Group: Neutralizing Antibody
Anti-PCSK9 Neutralizing Antibody |
BPS Bioscience |
50 µg |
EUR 555 |
Description: Neutralizing recombinant human antibody (IgG1) recognizing the LDLR binding region of human PCSK9. |
Anti-LAG3, Neutralizing Antibody |
BPS Bioscience |
100 µg |
EUR 530 |
Description: Neutralizing recombinant human antibody recognizing the Lag-3 binding region. |
Anti-VEGF Neutralizing Antibody |
BPS Bioscience |
50 µg |
EUR 355 |
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
Anti-VEGF Neutralizing Antibody |
BPS Bioscience |
100 g |
EUR 460 |
Description: Anti-VEGF recombinant Human antibody. This antibody not been tested for cross-reactivity with other species. |
Anti-VISTA Neutralizing Antibody |
BPS Bioscience |
100 µg |
EUR 450 |
Description: This human monoclonal antibody recognizes human V-domain immunoglobulin (Ig) suppressor of T cell activation (VISTA), and neutralizes its interaction with VSIG3 (also called IGSF11). VISTA is also known as B7-H5 or VSIR (GenBank Accession No. NM_022153). VSIG3 is a ligand involved in cell adhesion as a VISTA binding partner. This neutralizing antibody has been functionally tested using the VSIG-3:VISTA [Biotinylated] Inhibitor Screening Assay Kit (BPS Bioscience #79782). |
Anti-RANKL Neutralizing Antibody |
BPS Bioscience |
50 µg |
EUR 335 |
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain). |
Anti-RANKL Neutralizing Antibody |
BPS Bioscience |
100 µg |
EUR 460 |
Description: Human, recombinant monoclonal antibody recognizing the RANKL protein, also known as TNFSF11 antibody and CD254 antibody. This antibody recognizes human RANKL. It has not been tested with other species. MW= 50 kDa (Heavy chain); 24 kDa (Light chain). |
Neutralizing Antibody information
Rabbit Anti-Poliomyelitis Virus 2 (P712,Ch,2ab strain) antiserum, neutralizing |
POLV22-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
G. Pig anti-Poliomyelitis Virus 2 (sabin strain, native) antiserum, neutralizing |
POLV23-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Rabbit Anti-Poliomyelitis Virus 3 (Leon1,Ch,2ab strain) antiserum, neutralizing |
POLV32-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
G. Pig anti-Poliomyelitis Virus 3 (sabin strain, native) antiserum, neutralizing |
POLV33-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Mouse monoclona Anti-Rabies Virus Glycoprotein (RVG) IgG, neutralizing (clone 1) |
RBVGP12-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Mouse monoclona Anti-Rabies Virus Glycoprotein (RVG) IgG, neutralizing (clone 2) |
RBVGP13-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
AMM06679G |
Leading Biology |
0.05mg |
EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Anti-PD-1 Neutralizing Antibody, Biotin-labeled |
71215 |
BPS Bioscience |
100 µg |
EUR 510 |
Description: Purified, recombinant, human anti-PD-1 (IgG1) antibody with C-terminal Avitag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody does not cross-react with mouse PD-1, but does cross-react with monkey (M. fascicularis) PD-1. It has not been tested with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
100436-1 |
BPS Bioscience |
50 µg |
EUR 355 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-NGF (Nerve Growth Factor) Neutralizing Antibody |
100436-2 |
BPS Bioscience |
100 µg |
EUR 490 |
Description: Anti-NGF Neutralizing Recombinant Human antibody. This_x000D_ antibody has not been tested for crossreactivity_x000D_ with other species. |
Anti-PD-L1 Neutralizing Antibody, Biotin-labeled |
71214 |
BPS Bioscience |
100 µg |
EUR 510 |
Description: Purified, recombinant, chimeric murine/human anti-PD-L1 (IgG1) antibody with C-terminal Avi-tag, expressed in HEK293 cells. Purified antibody was enzymatically biotinylated using Avitag™ technology. This antibody reacts with human PD-L1 and cross-reacts with mouse PD-L1. It has not been tested for cross-reactivity with other species. |
Human Monoclonal Anti-Dengue Virus Type 1-4 Envelop protein Domiam III (Env-DIII) IgG1 (reacts with DV1-4 DIIII, neutralizing) |
DV1234E22-M |
Alpha Diagnostics |
100 ul |
EUR 578.4 |
Spike Neutralizing Antibody (Clone G10xA1) (SARS-CoV-2) |
101326 |
BPS Bioscience |
100 µg |
EUR 600 |
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2):ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience #78339). |
Spike Neutralizing Antibody (Clone G10xA5) (SARS-CoV-2) |
101327 |
BPS Bioscience |
100 µg |
EUR 600 |
Description: This monoclonal antibody recognizes the SARS-CoV-2 Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2 [Table of Variants]. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. ACE2 is known to mediate COVID-19 infection through direct binding of the SARS-CoV-2 Spike protein. This neutralizing antibody has been functionally tested using the Spike S1 RBD (B.1.1.529, Omicron Variant) (SARS-CoV-2): ACE2 Inhibitor Screening Colorimetric Assay Kit (BPS Bioscience, #78339). |
Anti-PCSK9 Neutralizing Antibody, (IgG1) Biotin-labeled |
71216 |
BPS Bioscience |
50 µg |
EUR 530 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG1) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This antibody reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |
Anti-PCSK9 Neutralizing Antibody, (IgG4) Biotin-labeled |
71217 |
BPS Bioscience |
50 µg |
EUR 515 |
Description: Purified recombinant human_x000D_anti-PCSK9 (IgG4) antibody with a C-terminal_x000D_Avi-tag, expressed in HEK293 cells. Purified_x000D_antibody was enzymatically biotinylated using_x000D_AviTag™ technology. This protein reacts with_x000D_human PCSK9 and has not been tested for_x000D_cross-reactivity with other species. |